Skip to main content
. 2023 Apr 21;37(6):1245–1253. doi: 10.1038/s41375-023-01906-z

Fig. 4. Clinical outcome of UBTF-TD AML 18–60 y.

Fig. 4

A Disease-free survival in patients achieving CR or CRp after induction and (B) overall survival according to UBTF status and ELN 2022 risk stratification. Study restricted to patients enrolled in the ALFA-0702 trial with available ELN 2022 risk stratification.